Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP)

NCT06724562 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06724562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06724562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP)
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2025
Completion date
November 5, 2027
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrodysplasia ossificans progressiva (fop)